We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.3B
AUM Growth
+$1.62B
Cap. Flow
+$896M
Cap. Flow %
7.96%
Top 10 Hldgs %
56.76%
Holding
110
New
30
Increased
24
Reduced
18
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Communication Services 19.94%
3 Healthcare 12.5%
4 Industrials 7.48%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRU icon
26
TransUnion
TRU
$16B
$110M 0.98%
+2,322,158
New +$106M
AZN icon
27
AstraZeneca
AZN
$269B
$108M 0.96%
1,590,000
+1,302,500
+453% +$82.3M
BUD icon
28
AB InBev
BUD
$164B
$107M 0.95%
+900,000
New +$105M
LBTYA icon
29
Liberty Global Class A
LBTYA
$3.59B
$101M 0.9%
2,992,935
-1,227,169
-29% -$40.9M
LBTYK icon
30
Liberty Global Class C
LBTYK
$3.5B
$101M 0.9%
3,089,773
-1,263,163
-29% -$40.8M
HUN icon
31
Huntsman Corp
HUN
$2.1B
$96M 0.85%
3,500,000
-1,920,000
-35% -$51.2M
CPN
32
DELISTED
Calpine Corporation
CPN
$95.3M 0.85%
+6,460,000
New +$92.2M
BMY icon
33
Bristol-Myers Squibb
BMY
$129B
$86.4M 0.77%
+1,355,000
New +$79.1M
HLF icon
34
Herbalife
HLF
$1.3B
$85.5M 0.76%
2,519,670
-1,678,736
-40% -$57.5M
FOLD
35
DELISTED
Amicus Therapeutics
FOLD
$76.6M 0.68%
5,081,055
+2,081,055
+69% +$27.5M
GILD icon
36
Gilead Sciences
GILD
$165B
$76.6M 0.68%
+945,000
New +$72.3M
AKRX
37
DELISTED
Akorn Inc
AKRX
$75.7M 0.67%
+2,280,000
New +$75.7M
CHTR icon
38
Charter Communications
CHTR
$17.3B
$69.5M 0.62%
191,255
-143,570
-43% -$53.4M
GNCMA
39
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$67.1M 0.6%
1,643,800
+1,004,824
+157% +$41M
CMCSA icon
40
Comcast
CMCSA
$87.3B
$67M 0.6%
1,741,621
-1,607,565
-48% -$63.3M
BRCD
41
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$61.3M 0.54%
+5,130,000
New +$63.4M
KYNB
42
Kyntra Bio
KYNB
$27.4M
$59.2M 0.53%
44,000
+1,120
+3% +$1.18M
ABBV icon
43
AbbVie
ABBV
$465B
$52M 0.46%
585,000
-250,000
-30% -$19M
ELV icon
44
Elevance Health
ELV
$81.5B
$39.9M 0.35%
210,000
RC
45
Ready Capital
RC
$260M
$36.5M 0.32%
2,324,236
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$35.9M 0.32%
+963,000
New +$33.4M
GRFS
47
Grifois
GRFS
$5.55B
$31.3M 0.28%
1,429,773
+349,899
+32% +$7.26M
ESV
48
DELISTED
Ensco Rowan plc
ESV
$29.4M 0.26%
+1,230,000
New +$24.5M
EXEL icon
49
Exelixis
EXEL
$13.9B
$28.8M 0.26%
1,190,000
-325,000
-21% -$8.65M
LKFT
50
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$24M 0.21%
+236,216
New +$20.6M

Similar funds

Farallon Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Farallon Capital Management held 110 positions worth $11.3B, up 17% from $9.63B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Farallon Capital Management deployed $896M of net new capital in Q3 2017, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Equifax: 1,290,000 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SBA Communications, an estimated $132M trimmed.

  • Farallon Capital Management's largest Q3 2017 buy was Equifax: 1,290,000 shares worth $137M.
  • Farallon Capital Management added most to Time Warner Inc in Q3 2017, an estimated $146M increase.
  • Farallon Capital Management's biggest Q3 2017 reduction was SBA Communications, cutting an estimated $132M.
  • Farallon Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $371M.
  • Farallon Capital Management's ten largest holdings make up 57% of its $11.3B portfolio in Q3 2017.
  • Farallon Capital Management opened 30 new positions and closed 25 in Q3 2017.
  • Farallon Capital Management's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on Farallon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.